The Transparency Paradigm: How to select the right CRO for your Endocrine Disruptor Screening Program needs
By Ronald C. Biever, Chief Scientific Officer
Although Contract Research Organizations (CROs) are likely a part of your company's current value chain, the new and unique challenges presented in the US EPA's Endocrine Disruptor Screening Program (EDSP) may compel you to rethink your CRO selection process.
In a new white paper from Smithers Viscient, titled "The Transparency Paradigm: How to select the right CRO for your Endocrine Disruptor Screening Program needs", Ronald C. Biever, Chief Scientific Officer, offers practical advice that can help to increase the likelihood of successfully completing EDSP testing for your organization.
The paper examines the 'Transparency Paradigm', a systematic and logical way to identify the right CRO for your organization's EDSP testing needs. Developing your own Transparency Paradigm will remove barriers and ensure that your selected CRO and program execution will meet your organization's specific requirements for this complex program. The criteria described in the Transparency Paradigm can assist in prioritizing your specific needs, clearly communicating your expectations, and complementing your constraints with a CRO's strengths.
Upon submitting, you will receive an email with a link to download the file.
